Rejection of guinea pig cardiac xenografts post-cobra venom factor therapy is associated with infiltration by mononuclear cells secreting interferon-gamma and diffuse endothelial activation
Hancock, W.W.; Blakely, M.L.; Van der Werf, W.; Bach, F.H.
Transplantation Proceedings 25(5): 2932
1993
ISSN/ISBN: 0041-1345 PMID: 8212288 Document Number: 422329
Document emailed within 1 workday
Related Documents
Kobayashi, T.; Taniguchi, S.; Ye, Y.; Niekrasz, M.; Kosanke, S.; Neethling, F.A.; Wright, L.J.; Rose, A.G.; White, D.J.; Cooper, D.K. 1996: Delayed xenograft rejection in C3-depleted discordant (pig-to-baboon) cardiac xenografts treated with cobra venom factor Transplantation Proceedings 28(2): 560Lesnikoski, B.A.; Shaffer, D.A.; Van der Werf, W.J.; Dalmasso, A.P.; Soares, M.P.; Latinne, D.; Bazin, H.; Hancock, W.W.; Bach, F.H. 1995: Endothelial and host mononuclear cell activation and cytokine expression during rejection of pig-to-baboon discordant xenografts Transplantation Proceedings 27(1): 290-291
Peng, M.H.; Meng, K.W.; Yang, D.H. 2001: The effect of Chinese cobra venom factor on guinea pig to rat cardiac xenotransplantation Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 15(4): 240-243
Shiau Lin, S.Y.; Su, S.C.; Lee, C.Y. 1976: Comparative studies on cytotoxin from the Indian cobra venom and cardiotoxin from the Formosan cobra venom, with special reference to the effect on the growth of Ehrlich ascites tumor cells in mice Journal of the Formosan Medical Association 75(6): 328-336
Kemp, E.; Steinbrüchel, D.; Starklint, H.; Larsen, S.; Henriksen, I.; Dieperink, H. 1987: Renal xenograft rejection: prolonging effect of captopril, ACE-inhibitors, prostacyclin, and cobra venom factor Transplantation Proceedings 19(6): 4471-4474
Li, Z-dong.; Shi, C-qing.; Zhang, Q-hua.; Xiong, Y-liang.; Zhou, X-ding.; Wang, W-yu.; Song, N. 2004: Mechanisms of purified cobra venom factor in preventing hyperacute rejection following discordant liver xenotransplantation in rats Zhonghua Yi Xue Za Zhi 84(23): 2007-2010
Hoopes, P.C.; McCall, C.E. 1977: The effect or cobra venom factor (CVJ) activation of the complement cascade on leukocyte circadian variation in the rat Experientia 33(2): 224-226
Fearon, D.T.; Austen, K.F.; Ruddy, S. 1973: Serum proteins involved in decay and regeneration of cobra venom factor-dependent complement activation Journal of Immunology 111(6): 1730-1736
Pruitt, S.K.; Baldwin, W.M.; Sanfilippo, F. 1996: The role of C3a and C5a in hyperacute rejection of guinea pig-to-rat cardiac xenografts Transplantation Proceedings 28(2): 596
Jayaram, Y.; Buckle, A.M.; Hogg, N. 1989: The Fc receptor, FcRI, and other activation molecules on human mononuclear phagocytes after treatment with interferon-gamma Clinical and Experimental Immunology 75(3): 414-420
Mauerhoff, T.; Belfiore, A.; Pujol-Borrell, R.; Bottazzo, G.F. 1994: Growth inhibition of human endothelial cells by human recombinant tumor necrosis factor alpha and interferon-gamma Tumori 80(4): 301-305
Xiang, J.; Moyana, T. 1998: Cytotoxic CD4+ T cells associated with the expression of major histocompatibility complex class II antigen of mouse myeloma cells secreting interferon-gamma are cytolytic in vitro and tumoricidal in vivo Cancer Gene Therapy 5(5): 313-320
Geller, R.L.; Bach, F.H.; Vercellotti, G.M.; Nistler, R.S.; Bolman, R.M.; Fischel, R.J.; Leventhal, J.; Platt, J.L. 1992: Activation of endothelial cells in hyperacute xenograft rejection Transplantation Proceedings 24(2): 592
Bacon, T.H.; Ozbakir, F.; Elms, C.A.; Denman, A.M. 1984: Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome Clinical and Experimental Immunology 57(3): 541-547
Christofinis, G.J. 1980: Heterospecific antiviral activity of human interferon on guinea pig endothelial cells Developments in Biological Standardization 46: 193-196
Esumi, N.; Hunt, B.; Itaya, T.; Frost, P. 1991: Reduced tumorigenicity of murine tumor cells secreting gamma-interferon is due to nonspecific host responses and is unrelated to class i major histocompatibility complex expression Cancer Research 51(4): 1185-1189
Arnman, V.; Stemme, S.; Rymo, L.; Risberg, B. 1995: Interferon-gamma modulates the fibrinolytic response in cultured human endothelial cells Thrombosis Research 77(5): 431-440
Lin, F.-f.; Chen, H.-z.; Xie, X.; Ye, D.-f. 2003: Down-regulation of vascular endothelial growth factor expression in ovarian cancer cell line SKOV3 by interferon-gamma Zhonghua Fu Chan Ke Za Zhi 38(3): 150-153; 3-1
Abramson, L.P.; Pahl, E.; Huang, L.; Stellmach, V.; Rodgers, S.; Mavroudis, C.; Backer, C.L.; Arensman, R.M.; Crawford, S.E. 2002: Serum vascular endothelial growth factor as a surveillance marker for cellular rejection in pediatric cardiac transplantation Transplantation 73(1): 153-156
Kohno, K.; Kataoka, J.; Ohtsuki, T.; Suemoto, Y.; Okamoto, I.; Usui, M.; Ikeda, M.; Kurimoto, M. 1997: IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12 Journal of Immunology 158(4): 1541-1550